NS 2028

CAS : 204326-43-2

Ref. 3D-EIA32643

Informations sur le produit

• Nom: NS 2028
• Synonymes: 1H,4H-[1,2,4]Oxadiazolo[3,4-c][1,4]benzoxazin-1-one, 8-bromo-, 4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)ben(b)(1,4)oxazin-1-one, 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one, Ns 2028
• CAS: 204326-43-2

Description

NS 2028 is an inhibitor of cyclase, a signal transduction protein that is responsible for the conversion of inactive GTP to active cGMP. NS 2028 inhibits the production of cGMP by binding to and blocking the active site on cyclase, which prevents the phosphorylation and activation of downstream cellular proteins. NS 2028 has been shown to inhibit the light-induced oxidative stress response in a human prostate cancer cell line (Du-145) by reducing intracellular calcium levels and inhibiting signal pathways that lead to mitochondrial membrane potential disruption.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 269.05 g/mol
• Formule: C₉H₅BrN₂O₃
• Degré de pureté: Min. 95%